Pharmaceutical company

We all live, we rejoice, we grieve, we are interested in new technologies, space, e-commerce, tourism… And this is our life, and this life is beautiful! But all this loses its meaning and significance if we have a headache or a toothache :)! Now we are no longer up to space technology :). But we ate a pill, the tooth (head) stopped hurting and we again enjoy life and develop space technologies… But there are also much more serious problems: heart attack, stroke, oncology, deadly viral infections, disability .There are a lot of drugs on the pharmaceutical market, but even more unsolved problems.And we can help many people producing new drugs.

Another promising direction is the beauty segment. People want to be healthy and beautiful (especially women :)). And here we can help too :)

Our four-legged friends also need attention and care :) And here we can also help.

Currently, the global pharmaceutical market is over $ 1.2 trillion.

In the period 2016-2025 the global pharmaceutical market (including biotechnology) will grow by an average of 4.6%, and by 2025 its volume will amount to $ 1.7 trillion.

The leader is the US pharmaceutical market, the Chinese pharmaceutical market firmly holds the second place in the world ranking and reaches 165 billion US dollars.

For example, in Russia is about 20 billion USD, in Poland 11 billion USD, in Germany 55 billion USD .

The global cosmetic market also shows growth and in 2018 amounted to more than 500 billion dollars.Moreover, more than half of the volume is occupied by hair and skin care products (shampoos and creams).The undoubted advantage is the positioning of cosmetics for daily use «from the pharmaceutical company.»

The uniqueness of the project lies in the fact that the company focuses primarily on original, non-generic, products that are protected by a patent. At the same time, we are not focusing on one segment, for example, neurology or ophthalmology, we plan to cover all perspective areas with unmet needs. And due to this, we bring the maximum benefit to our customers and, accordingly, we profit from the sale of a large product portfolio.

Our strategic goal is to create maximum loyalty to the brand, and not behavioral (buying a branded product without emotional attachment), but affective, based on emotional attachment to the brand.

This is possible with the highest quality products and honesty in dealing with partners.

And we are talking about the formation of loyalty both to a specific product and to the company as a whole.

More specifically, a separate launch strategy and product image is developed for each product, depending on the characteristics of the product itself and the competitive environment.

All products can be divided into two segments: for doctors (prescription pharmaceuticals) and for clients (non-prescription pharmaceuticals and cosmetics).

Accordingly, each segment has its own sales strategies. Moreover, for each geographic region, a different strategy should be developed for each product. This is due to the demographic, socio-cultural characteristics and different competitive environments.

This applies to both prescription drugs that are promoted only among doctors and pharmacies, and non-prescription drugs and cosmetics that are promoted to end-users (advertising).